Figure 2.
Figure 2. BCR and Ox Phos DLBCL cell lines exhibit differential sensitivity to the BCL6 peptide inhibitor (BPI). / Proliferation of BPI-treated BCR and Ox Phos DLBCL cell lines. Cell lines were treated with 20 μM BPI.

BCR and Ox Phos DLBCL cell lines exhibit differential sensitivity to the BCL6 peptide inhibitor (BPI).

Proliferation of BPI-treated BCR and Ox Phos DLBCL cell lines. Cell lines were treated with 20 μM BPI.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal